We are live on ! Find out more
HZNP

Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP

Delisted

HZNP was delisted on the 5th of October, 2023.

Back to rankings

1 hedge funds and large institutions have $116 invested in Horizon Therapeutics Public Limited Company Ordinary Shares in 2026 Q2 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 1 → 1 (0)

0% more capital invested

Capital invested by funds: $116 → $116 ($0)

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

HZNP Hedge Fund Activity: Q2 2026 in Review

1 of the 8,343 institutional investors tracked by Wall St. Rank reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) for Q2 2026, worth a combined $116 — unchanged from a quarter earlier.

Fund positioning in HZNP was balanced in Q2 2026: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 1 institutional investor held Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) as of Q2 2026, unchanged from Q1 2026.
  • Funds reported $116 of Horizon Therapeutics Public Limited Company Ordinary Shares stock for Q2 2026, unchanged quarter-over-quarter.
  • 0 funds opened new Horizon Therapeutics Public Limited Company Ordinary Shares positions in Q2 2026 and 0 closed out.

Based on aggregated 13F filings for Q2 2026.